Tilray is moving in the right direction, but it still isn't a sustainably profitable business.
Holding this stock has been a painful lesson about cutting your losses.
Tilray Brands stock has moved sideways in the past few weeks, moving from last October’s high of $23 to the current $7.93. This consolidation happened as the hype surrounding the rescheduling of ...
Tilray Brands has struggled to stay out of the red over the years, and that pattern may continue for the foreseeable future. The company's growth prospects are underwhelming. Tilray Brands (NASDAQ: ...
Don't bet on either one to pull that off.
Tilray Brands (NASDAQ: TLRY), like many other cannabis stocks, has taken investors on a wild roller-coaster ride the past few ...
Tilray will reverse split its stock 10-for-1 on Monday. The shares will resume trading Tuesday morning at a share price close to $8. On June 10, 2025, Tilray authorized Tilray to reverse-split its ...
Tilray stock rocketed on Monday on rumors the U.S. might legalize marijuana soon. In Germany, Tilray is expanding medical marijuana production. Tilray is losing a lot of money even as its other news ...
UKRAINE - 2021/02/21: In this photo illustration a Tilray logo of a Canadian pharmaceutical and cannabis company, is seen on a smartphone and a pc screen. (Photo Illustration by Pavlo Gonchar/SOPA ...
Shares of Tilray Brands rocketed Friday amid rising hope that cannabis is finally on the doorstep of being rescheduled as a lower-class drug, which could open doors for further legalization and ...
Tilray reported a surprise profit yesterday. The share price went up -- and Tilray cashed in by announcing a big share sale. 37.3 million Tilray shares could soon flood onto the market. Tilray Brands ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results